Position in VRDN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,690,972
-$12,210,443 QoQ
Shares Held
581,980
-50.3% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#46
of 215 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $5,490,398,452 across 69 Biotechnology names. VRDN ranks #52 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $681,627,752 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
4,319,496 | $383,484,854 | |
| 3 | CELC |
Celcuity Inc.
|
3,197,200 | $334,491,064 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,163,721 | $310,387,665 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,586,295 | $287,156,333 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
8,085,461 | $286,144,464 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
14,106,187 | $263,926,758 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
3,752,574 | $213,183,728 |
All Filings in VRDN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,690,972 | 581,980 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,901,415 | 1,170,829 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $94,688,917 | 3,042,703 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $31,558,592 | 1,462,400 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,256,147 | 447,507 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,892,243 | 659,662 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $28,496,358 | 1,486,508 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $63,988,128 | 2,812,665 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,230,082 | 1,631,828 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $64,035,803 | 3,657,099 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $37,684,017 | 1,730,212 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $15,511,884 | 1,011,205 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,260,222 | 1,776,386 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $44,173,659 | 1,736,386 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $35,652,995 | 1,220,575 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,033,993 | 1,220,575 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,244,096 | 971,832 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,312,249 | 1,423,053 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $28,133,757 | 1,423,053 | Shares | Sole | 2022-04-13 | |
| 2021-09-30 | $23,408,350 | 1,423,000 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $14,531,514 | 794,506 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||